Related Articles
Imatinib mesylate and nilotinib decrease synthesis of bone matrix in vitro
Off‑target effect of imatinib and nilotinib on human vitamin D3 metabolism
In vitro effects of imatinib on CD34+ cells of patients with chronic myeloid leukemia in the megakaryocytic crisis phase
Proteomic analysis of imatinib-resistant CML-T1 cells reveals calcium homeostasis as a potential therapeutic target
Nilotinib rapidly reverses breakpoint cluster region-Abelson oncogene fusion gene and M244V mutations in a patient with chronic myelogenous leukemia: A case report